Byakangelicol
Byakangelicol may inhibit P-gp expressed at the BBB even under in vivo conditions. Byakangelicol can inhibit IL-1beta-induced PGE2 release in A549 cells; this inhibition may be mediated by suppression of COX-2 expression and the activity of COX-2 enzyme, thus it may have therapeutic potential as an anti-inflammatory drug on airway inflammation.
Product Specifications
CAS Number
26091-79-2
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 50 mg/mL (158.07 mM)
Smiles
CC1 (C (O1) COC2=C3C (=C (C4=C2OC (=O) C=C4) OC) C=CO3) C
Molecular Formula
C17H16O6
Molecular Weight
316.3
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
